Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$52.3M |
| 2 |
Exelon
EXC
|
+$51.9M |
| 3 |
Linde
LIN
|
+$48.3M |
| 4 |
Advanced Micro Devices
AMD
|
+$41.5M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$39.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$251M |
| 2 |
Microsoft
MSFT
|
+$235M |
| 3 |
Amazon
AMZN
|
+$226M |
| 4 |
CoStar Group
CSGP
|
+$103M |
| 5 |
AerCap
AER
|
+$82.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.96% |
| 2 | Industrials | 12.92% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Financials | 9.27% |
| 5 | Energy | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFWM
1326
DELISTED
First Foundation Inc
FFWM
| $738K | 0.01% |
+30,363
| New | +$789K |
|
|
COLIU
1327
DELISTED
Colicity Inc. Units
COLIU
| $738K | 0.01% |
75,000
| – | – |
|
1328
Dave Inc
DAVE
$4.53B
| $735K | 0.01% |
+3,212
| New | +$773K |
|
|
OLPX
1329
DELISTED
Olaplex Holdings
OLPX
| $735K | 0.01% |
47,013
-114,104
| -71% | -$2.18M |
|
|
TPH
1330
DELISTED
Tri Pointe Homes
TPH
| $733K | 0.01% |
36,500
-3,453
| -9% | -$80.2K |
|
|
SWAV
1331
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $732K | 0.01% |
+3,529
| New | +$582K |
|
|
LPRO
1332
DELISTED
Open Lending Corp
LPRO
| $730K | 0.01% |
38,615
-4,453
| -10% | -$85.5K |
|
1333
Penske Automotive Group
PAG
$14.3B
| $727K | 0.01% |
+7,761
| New | +$785K |
|
1334
Red Rock Resorts
RRR
$3.59B
| $723K | 0.01% |
+14,893
| New | +$710K |
|
1335
CNX Resources
CNX
$5.4B
| $721K | 0.01% |
34,779
+3,637
| +12% | +$60.5K |
|
1336
American Financial Group
AFG
$12B
| $720K | 0.01% |
4,945
-3,456
| -41% | -$471K |
|
1337
Aramark
ARMK
$15.6B
| $720K | 0.01% |
+26,514
| New | +$691K |
|
1338
Franklin Templeton
BEN
$17.6B
| $719K | 0.01% |
+25,770
| New | +$787K |
|
|
AVNS
1339
DELISTED
Avanos Medical
AVNS
| $718K | 0.01% |
21,428
+12,212
| +133% | +$393K |
|
|
IMGN
1340
DELISTED
Immunogen Inc
IMGN
| $717K | 0.01% |
150,705
+108,428
| +256% | +$600K |
|
1341
Heritage Financial
HFWA
$1.19B
| $716K | 0.01% |
28,585
+1,046
| +4% | +$26.7K |
|
|
KNDI
1342
Kandi Technologies Group
KNDI
$65.1M
| $716K | 0.01% |
+223,738
| New | +$711K |
|
1343
Outfront Media
OUT
$5.36B
| $708K | 0.01% |
25,290
-17,561
| -41% | -$452K |
|
|
UHT
1344
Universal Health Realty Income Trust
UHT
$582M
| $708K | 0.01% |
12,133
+6,360
| +110% | +$369K |
|
1345
Genco Shipping & Trading
GNK
$1.17B
| $707K | 0.01% |
29,950
-28,416
| -49% | -$526K |
|
|
RSVR
1346
Reservoir Media
RSVR
$646M
| $706K | 0.01% |
71,837
+49,017
| +215% | +$368K |
|
|
RKLY
1347
DELISTED
Rockley Photonics Holdings Limited
RKLY
| $706K | 0.01% |
175,104
+152,849
| +687% | +$607K |
|
1348
Century Communities
CCS
$1.97B
| $702K | 0.01% |
13,097
+4,926
| +60% | +$316K |
|
|
BRMK
1349
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $702K | 0.01% |
81,188
-179,119
| -69% | -$1.6M |
|
1350
Baker Hughes
BKR
$61.5B
| $696K | 0.01% |
+19,111
| New | +$580K |
|
Similar funds
Michael Gelband's Q1 2022 Portfolio in Review
As of Q1 2022, Michael Gelband held 2,902 positions worth $7.91B, down 18% from $9.67B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Michael Gelband withdrew a net $1.37B in Q1 2022, closing 758 positions and reducing 576 holdings. Its most notable exit was CoStar Group, an estimated $103M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Michael Gelband opened a new position in Linde worth $49.9M.
- Michael Gelband's largest Q1 2022 buy was Linde: 156,289 shares worth $49.9M.
- Michael Gelband added most to ExxonMobil in Q1 2022, an estimated $52.3M increase.
- Michael Gelband's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $251M.
- Michael Gelband fully exited CoStar Group in Q1 2022, selling an estimated $103M.
- Michael Gelband's ten largest holdings make up 11% of its $7.91B portfolio in Q1 2022.
- Michael Gelband opened 788 new positions and closed 758 in Q1 2022.
- Michael Gelband's portfolio value fell 18% quarter-over-quarter to $7.91B.
Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.